Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
Spago Nanomedcal
-
search results
If you're not happy with the results, please do another search
Spago on the increased dose in Tumorad-01
4 April, 2025
Spago takes Tumorad-01 study to the next level
6 March, 2025
Spago’s CEO: “We want to expand cancer treatment with effective radiopharmaceuticals”
19 December, 2024
Investing in life science: From Seed to Success 2024
16 September, 2024
Spago Nanomedical strengthened management to reflect project progress
5 September, 2024
Spago’s CEO: Advancing the Tumorad programme comes first
7 May, 2024
Spago Nanomedical’s CEO: “huge commercial opportunities are unfolding”
27 March, 2024
2023 springboard for Spago’s radionuclide cancer therapy
9 February, 2024
Spago’s phase I/IIa cancer trial progressing steadily
15 January, 2024
Positive data in Spago’s phase IIa endometriosis trial
20 December, 2023
First patient dosed in Spago’s phase I/IIa trial
14 December, 2023
All sessions from BioStock Life Science Fall Summit 2023
30 October, 2023
Tumorad’s potential in transforming cancer care
30 October, 2023
Video from day 1 of BioStock Life Science Fall Summit 2023
26 October, 2023
Spago Nanomedical’s promising cancer therapy approved for phase I/IIa
23 October, 2023
Spago Nanomedical’s SAB on Tumorad’s potential
29 June, 2023
Spago Nanomedical’s CDO on study submission
30 May, 2023
Tumorad clinical start around the corner for Spago Nanomedical
16 May, 2023
BioStock Life Science Summit 2023
20 March, 2023
Analysis sees brighter times ahead for biotech
8 March, 2023
BioStock Life Science Summit 2023
22 February, 2023
Spago Nanomedical reports advancement
8 February, 2023
Spago Nanomedical publishes positive preclinical data
12 January, 2023
Spago Nanomedical’s CDO on the endometriosis study
8 December, 2022
Spago Nanomedical starts phase IIa study in endometriosis
6 December, 2022
Spago Nanomedical in hot biotech area
13 September, 2022
Spago Nanomedical on the autumn newsflow
26 August, 2022
Spago Nanomedical progresses towards clinical phase with Tumorad
5 July, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
Spago Nanomedical on project potential
3 May, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
Spago Nanomedical looks ahead
8 February, 2022
Spago Nanomedical on the progress with Tumorad
28 January, 2022
Positive interim results from Spago Nanomedical
17 January, 2022
Spago Nanomedical prepares for an eventful 2022
15 December, 2021
Join us for the BioStock Life Science Summit on October 20...
20 October, 2021
Spago Nanomedical’s CDO is in place
12 October, 2021
Spago Nanomedical’s CEO about the plans for the coming twelve months
28 June, 2021
Spago Nanomedical enters Nasdaq First North Growth Market
26 March, 2021
Spago Nanomedical on the oversubscribed rights issue and the plan ahead
5 March, 2021
Watch company presentations & panels from the BioStock Life Science Summit...
29 November, 2020
Strong line-up at the BioStock Life Science Summit 2020
16 November, 2020
Strong opening to BioStock Life Science Summit 2019 – see videos...
31 October, 2019
Start
10 September, 2015
